Evidence map›Paper›PMID 30069276›Full record

Observational studyDisease markers2018

High Circulating Caspase-Cleaved Keratin 18 Fragments (M30) Indicate Short-Term Mortality in Critically Ill Patients.

Alexander Koch, Eray Yagmur, Janine Linka, Fabienne Schumacher, Jan Bruensing, Lukas Buendgens, Ulf Herbers, Ger H Koek, Ralf Weiskirchen, Christian Trautwein and 1 more

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Disease markers, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Serum/Plasma Proteome in Non-Malignant Liver Disease.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Article
  6. Differential Gene Expression in Circulating CD14Journal of clinical medicine · 2020
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Alexander KochDepartment of Medicine III, RWTH-University Hospital Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany.
Eray YagmurMedical Care Center, Dr. Stein and Colleagues, Mönchengladbach, Germany.
Janine LinkaDepartment of Medicine III, RWTH-University Hospital Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany.
Fabienne SchumacherDepartment of Medicine III, RWTH-University Hospital Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany.
Jan BruensingDepartment of Medicine III, RWTH-University Hospital Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany.
Lukas BuendgensDepartment of Medicine III, RWTH-University Hospital Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany.ORCID 0000-0003-3677-8511
Ulf HerbersDepartment of Medicine III, RWTH-University Hospital Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany.
Ger H KoekSection of Gastroenterology and Hepatology, Department of Internal Medicine, Maastricht University Medical Centre (MUMC), Maastricht, Netherlands.
Ralf WeiskirchenInstitute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry, RWTH-University Hospital Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany.ORCID 0000-0003-3888-0931
Christian TrautweinDepartment of Medicine III, RWTH-University Hospital Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany.
Frank TackeDepartment of Medicine III, RWTH-University Hospital Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany.ORCID 0000-0001-6206-0226
Universitätsklinikum Aachen · DEMaastricht University Medical Centre · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Caspase-cleaved fragments of the intermediate filament protein keratin 18 (cytokeratin-18 (CK18)) can be detected in serum as M30 levels and may serve as a circulating biomarker indicating apoptosis of epithelial and parenchymal cells. In order to evaluate M30 as a biomarker in critical illness, we analyzed circulating M30 levels in 243 critically ill patients (156 with sepsis, 87 without sepsis) at admission to the medical intensive care unit (ICU), in comparison to healthy controls (

Indexed as

AdolescentAdultAgedApoptosisBiomarkersCase-Control StudiesCaspasesCritical IllnessFemaleHumansKeratin-18MaleMiddle AgedPeptide FragmentsSepsisBiomarkersCaspasesKeratin-18M30 cytokeratin-18 peptide, humanPeptide Fragments

Identifiers

PMID30069276
PMCPMC6057335
OpenAlexW2836770468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.